Molecular Templates (MTEM)
(Delayed Data from NSDQ)
$1.58 USD
-0.08 (-4.82%)
Updated Apr 17, 2024 04:00 PM ET
After-Market: $1.58 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth A Momentum B VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 37% (145 out of 251)Zacks Sector Rank
Top 13% (2 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.52 | 9.99 |
Current Quarter Estimate | NA | -2.04 | 60.00 |
Year Ago Quarter Estimate | 2.85 | -0.59 | 52.54 |
Next Quarter Estimate | NA | -2.00 | 61.00 |
Next Year Estimate | -2.85 | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -20.00 | 9.70 | 17.08 |
Next Year | -5.56 | 13.60 | 8.00 |
Last 5 Years | NA | 5.90 | 8.10 |
Next 5 Years | NA | 22.20 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -5.88 |
Price/Book (MRQ) | 2.12 | 1.87 |
Price/Cash Flow (MRFY) | NA | 9.05 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -14.18% | -19.76% |
Return on Equity (TTM) | -9,335.53% | -72.91% |
Debt to Equity (MRQ) | NA | 0.30 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.